| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0009 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |